A possible involvement of ion transporter in tumor necrosis factor alpha and cycloheximide-induced apoptosis of endothelial cells. by Fujita, H et al.
A possible involvement of ion
transporter in tumor necrosis factor
a and cycloheximide-induced






1Department of Internal Medicine, Tokyo
Metropolitan Bokutou General Hospital, Sumida-ku,
Tokyo; and 
2Department of Physiological Chemistry,
Graduate School, Tokyo Medical and Dental
University, 1–5–45 Yushima, Bunkyo-ku, Tokyo 113,
Japan
CACorresponding Author
Present Address: Department of Internal Medicine,
Tokyo Metropolitan Bokutou General Hospital, 4–23–15
Koutoubashi, Sumida-ku, Tokyo 130–8575, Japan
Tel: (+81) 3 3633 6151
Fax: (+81) 3 3633 6173
WE examined  the  tumor  necrosis  factor  a (TNFa )-
induced apoptosis of vascular endothelial cells from
the  standpoint  of  ion  channels.  Cultured  vascular
endothelial  cells  from  bovine  carotid  artery  were
used.  Apoptosis  was  determined  by  a  propidium
iodide assay. Treatment of the endothelial cells with
TNFa and  cycloheximide  for  6 h  induced  nuclear
fragmentation  in  a  TNFa dose-dependent  manner
(1–10 ng/ml).  Concomitant  treatment  of  endothelial
cells with TNFa at a dose of 10 ng/ml and cyclohex-
imide at a dose of 10 m g/ml elicited endothelial cell
apoptosis as high as 23.4±4.1% at 6 h after administra-
tion.  However,  10 ng/ml TNFa alone elicited a little
apoptosis at  6 h after its administration (%  apopto-
sis=4.1±0.8%).  Cycloheximide  (10 m g/ml)  did  not
induce  apoptosis  at  all.  Concomitant  treatment  of
endothelial cells with 1 mmol/l of 4,4-diisothiocyana-
tostilbene-2,2-disulfonic  acid,  which  is  a  chloride
bicarbonate  exchanger  blocker,  partially  inhibited
the TNFa and cycloheximide-induced endothelial cell
apoptosis. On the other hand, endothelial cell apop-
tosis due to TNFa and cycloheximide was completely
inhibited  by  benzyloxycarbonyl-Asp-CH2OC(O)-
2,6-dichlorobenzene (50 m mol/l), an inhibitor of cas-
pase.  Moreover,  pyrrolidine  dithiocarbanate,  an
inhibitor  of  nuclear  factor  kappa  B  (NF-k B),  also
suppressed  endothelial  cell  apoptosis  induced  by
TNFa and cycloheximide completely. These findings
suggest that the endothelial cell apoptosis induced by
TNFa and cycloheximide is closely related to not only
chloride  ions,  but  also  both  NF-k B  and  caspase
activation.  That  is to say,  there is a possibility that
chloride  ions  or  bicarbonate  (pH)  may  play  an
important role in signal transduction such as NF-k B
and  caspase activation in  the  apoptosis  induced  by
TNFa and cycloheximide.
Key  words:  Apoptosis, Tumor  necrosis  factor,  Chloride
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Introduction
Apoptosis (programmed cell death) is a fundamental
process  in  embryogenesis,  tissue  hemostasis,  and
immune  system  maturation.1 Its  deregulation  may
have  important  implications  for  carcinogenesis  and
immune system disorders. It has been reported that
apoptosis plays an  important  role in  various patho-
physiological conditions such as hypoxia/reperfusion
injury, radiation pneumonitis, etc.2,3 Endothelial cell
apoptosis has been observed when endothelial cells
are exposed to basic fibroblast growth factor deple-
tion.4 Lung injury such as pulmonary edema due to
radiation  is  based  on  endothelial  cell  apoptosis.3
Moreover,  lupus  anticoagulant-induced  apoptosis  of
endothelial  cells with  recognition  of annexin V has
been  reported.5 It  was  suggested  that  apoptosis  of
endothelial cells may be responsible for the vasculitis
associated with systemic lupus erythematosus. Thus,
endothelial  cell  apoptosis  may  cause  the  various
pathological conditions.
Tumor necrosis factor  a (TNFa ) is an  inducer of
apoptosis in various cells as well as an inflammatory
cytokine. TNFa activated  the  Fas-associated  protein
with death domain (FADD) through the receptor of
TNFa ,  subsequently  caused  the  activation  of  the
caspase, resulting in apoptosis.6 TNFa receptor bind-
ing  protein, TRAF2, elicited  nuclear  factor  kappa  B
(NF-k B) activation, which has an inhibitory action on
caspase activity.7 On the other hand, ceramide, which
is  produced  from  sphigomyelin  due  to  activated
sphingomyelinase by TNFa , can also induce both NF-
k B and apoptosis.8
In  the  present  study,  we  show  that  TNFa can
induce  apoptosis of  endothelial  cells concomitantly
with cycloheximide. This apoptosis was inhibited by
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nate (PDTC) or a caspase inhibitor. Moreover, we will
demonstrate that 4,4-diisothiocyanatostilbene-2,2-dis-
ulfonic acid (DIDS), a blocker of chloride bicarbonate
exchanger,  can  prevent  TNFa and  cycloheximide-
induced apoptosis of endothelial cells.
Materials and methods
Reagents
Human recombinant TNFa was purchased from Endo-
gen  Inc.  (NY)  DIDS,  5-N,  N-dimethyl  amiloride,
propidium iodide (PI), PDTC, N-acetyl cysteine (NAC)
and anthracene carboxylic acid were purchased from
Sigma  Co.  Ltd  (St.  Louis,  MO).  Benzyloxycarbonyl-
Asp-CH2OC(O)-2,6-dichlorobenzene  (zD-dcb)  was
purified as described previously.9
Endothelial cell culture
Endothelial  cells  were isolated from  freshly excised
bovine  carotid  arteries  as  described  previously.10
Briefly,  endothelial  cells  were  obtained  by  lightly
scraping the intimal surface of longitudinally opened
vessels. The cells were then seeded into 60mm dishes
(Falcon  Labware, Division  of Becton  Dickinson  and
Company,  Lincoln  Park,  NJ)  in  a  growth  medium
containing minimum essential medium (MEM) (Gibco
Laboratories, Grand  Island, NY) supplemented with
20% heat-inactivated fetal calf serum (FCS) (Intergen
Co. Purchase, NY), penicillin, and streptomycin (2%
total medium volume, Gibco Laboratories) and sub-
cultured in a 10% FCS-containing MEM. Cultures were
maintained in a humidified incubator at 37°C under
95% air/5% CO2, and were identified as endothelial
cells from their typical cobblestone appearance and
their incorporation activity of acetylated low-density
lipoprotein.  For  experimental  use,  the  endothelial
cells (passage levels under 20) were plated in 24-well
dishes  (Corning  Glass  Works,  Corning,  NY).  Cells
were plated in eight-well slide chambers (Nunc Inc.,
Herlev, Denmark) for PI stainings.
Apoptosis
Apoptosis  was  determined  from  the  presence  of
nuclear  fragmentation  on  PI  staining.11 Cells  were
fixed with 70% alcohol for 10min at 4°C. After being
washed  with  phosphate-buffered  saline,  the  cells
were  treated  with  PI  solution  (0.01g/l)  containing
RNAse (100mg/l) for 30min at 37°C. Following the
incubation,  the  nuclear  fragmentation  (over  2) was
observed  using  a  fluorescence  microscope  (Nikon
microphoto-FX, Nikon Japan Co., Tokyo, Japan), and
cells (endothelial cells, 100 cells) were counted in 10
different fields chosen at random. The percentage of
cells that underwent apoptosis was calculated using
the formula: % apoptosis=(apoptotic cells/total coun-
ted cells) 3 100.
Viability assay
Cell viability was evaluated using a 3–4,5-dimethylth-
iazol-2-yl-2,5-diphenyltetrazolium  bromide  (MTT)
assay.12 Briefly,  endothelial  cells  were  seeded  into
96-well dishes (Corning). The cells were treated with
TNFa (1–10ng/ml) and cycloheximide (10 m g/ml) for
6 h, and the MTT solution (200mg/l) was then added.
Thirty minutes later, dimethylsulfoxide was added to
dissolve  the  cells. The  fluorescence  at  570nm  was
measured.  The  cell  survival  rate  was  expressed
according to the formula: % survival rate= [(test value
– blank value)/(maximal value – blank value)] 3 100,
where the blank value represents the cell-free dish,
and  the  maximal  value  represents  the  fluorescence
from the total cells.
Statistical analysis
Data are expressed as the mean ± standard  error of
the mean (SEM). For comparisons of the mean values
between  two  subsets  of  data,  Student’s  t-test  was
used, employing the standard criterion of P<0.01 or
P<0.05  to  indicate  statistically  significant
differences.
Results
TNFa -induced apoptosis of endothelial cells
concomitantly with cycloheximide
We  examined  the  effect  of TNFa (1–10ng/ml)  on
endothelial cells. Control endothelial cells displayed a
typical cobblestone morphology, but their treatment
with 1–10ng/ml of TNFa for 6 h caused a little cell
shrinkage.  Concomitant  treatment  with  TNFa
(1–10ng/ml)  and  cycloheximide  (10m g/ml)  caused
severe cell shrinkage for 6 h. To determine whether
the  cell  damage  was  due  to  apoptosis  or  not,  we
stained the cells with propidium iodide. The nuclei of
the control endothelial cells were round, whereas the
TNFa (10ng/ml) and cycloheximide (10 m g/ml) trea-
ted cells revealed nuclei that were fragmented. The
dose dependency of the TNFa effect on the apoptosis
is  illustrated  in  Fig.  1.  Cycloheximide  (10 m g/ml)
given alone affected neither the morphology nor the
apoptosis induction (Fig. 1).
Prevention by the NF-k B inhibitor, PDTC, of
TNFa and cycloheximide-induced apoptosis of
endothelial cells
Concomitant  treatment  of  endothelial  cells  with
PDTC (1 mmol/l) completely inhibited the TNFa and
cycloheximide-induced  morphological  changes,  and
H. Fujita et al.
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FIG. 1. Apoptosis of endothelial cells treated with TNFa and cycloheximide. Endothelial cell monolayers were treated with
1–10ng/ml TNFa in the presence or absence of cycloheximide (CHX) (10m g/ml) for 6h. After the incubation treatment, the cells
were stained with PI, as described in Materials and methods. The percentage of apoptotic endothelial cells represents the
number of apoptotic cells in the counted 100 cells (apoptotic cells + viable cells). The data show the mean±SEM for 10 wells.
* P<0.05 versus TNFa -treated group. Each experiment was repeated three times.
FIG. 2. PDTC-inhibited TNFa and cycloheximide-induced apoptosis of endothelial cells. (A) Endothelial cell monolayers were
treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in various concentrations of PDTC (0–1mmol/l) for 6h. After the
incubation treatment, the cells were stained with propidium iodide, as described in Materials and methods. ** P<0.01 versus
TNFa and cycloheximide-treated group. Each experiment was repeated three times. (B) Endothelial cell monolayers were
treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence or absence of PDTC (1mmol/l) for 6h. After the
incubation treatment, the cells were stained with MTT, as described in Materials and methods. The data show the mean±SEM
for eight wells. 
#P<0.05 versus TNFa and cycloheximide-treated group. Each experiment was repeated three times.nuclear fragmentation of the cells, as demonstrated in
Fig. 2A. PDTC (1 mmol/l) given alone affected neither
the morphology nor the apoptosis induction. PDTC
suppressed  the  TNFa and  cycloheximide-induced
endothelial cell apoptosis in a dose-dependent man-
ner,  as  shown  in  Fig.  2A.  PDTC  also  reversed  the
decreased survival rate caused by TNFa and cyclohex-
imide in  a  dose-dependent  manner (Fig. 2B). PDTC
given alone did not influence the cell survival rate.
NAC, another inhibitor of NF-k B, did not suppress
the TNFa and cycloheximide-induced apoptosis (NAC
1 mmol/l; % inhibition=0.3±4.0%).
Effect of the sphigomyelinase inhibitor,
L-cycloserine, and the tyrosine phosphatase
inhibitor, vanadate, on endothelial cell
apoptosis induced by TNFa and cycloheximide
Concomitant  treatment  of  endothelial  cells  with
L-cycloserine  (an  inhibitor  of  sphingomyelinase,
1–10mmol/l) did not inhibit the TNFa and cyclohex-
imide-induced nuclear fragmentation of the cells, as
demonstrated in Fig. 3A. The phosphatase inhibitor,
sodium vanadate (1 mmol/l), completely inhibited the
TNFa and  cycloheximide-induced  apoptosis,  as
shown in Fig. 3B.
Protective effect of the caspase inhibitor,
zD-dcb, on endothelial cell apoptosis induced
by TNFa and cycloheximide
Concomitant treatment of endothelial cells with zD-
dcb (a caspase inhibitor, 50 m mol/l) completely inhib-
ited  the  TNFa and  cycloheximide-induced  nuclear
fragmentation of the cells, as demonstrated in Fig. 4A.
zD-dcb  suppressed  the  TNFa and  cycloheximide-
induced endothelial cell apoptosis in a dose-depend-
ent manner, as shown in Fig. 4A. zD-dcb also reversed
the decreased survival rate caused by the TNFa and
cycloheximide  in  a  dose-dependent  manner  (Fig.
4B).
Effects of ion transport inhibitors on
endothelial cell apoptosis induced by TNFa and
cycloheximide
Concomitant  treatment  of  endothelial  cells  with
DIDS  (a  chloride  bicarbonate  exchanger  blocker,
H. Fujita et al.
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FIG. 3. Effects of L-cycloserine and vanadate on TNFa and cycloheximide-induced apoptosis of endothelial cells. (A) Endothelial
cell monolayers were treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence or absence of L-cycloserine
(1–10mmol/l) for 6h. After the incubation treatment, the cells were stained with propidium iodide, as described in Materials
and methods. The percentage of apoptotic endothelial cells represents the number of apoptotic cells in the counted 100 cells
(apoptotic cells+viable cells). The data show the mean±SEM for 10 wells. (B) Endothelial cell monolayers were treated with
TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence or absence of sodium vanadate (0.01–1mmol/l) for 6h. After the
incubation treatment, the cells were stained with propidium iodide, as described in Materials and methods. The percentage of
apoptotic endothelial cells represents the number of apoptotic cells in the counted 100 cells (apoptotic cells+viable cells). The
data  show the  mean±SEM  for  10  wells. ** P<0.01 versus TNFa and cycloheximide-treated value. Each experiment was
repeated three times.1 mmol/l), in part, inhibited the TNFa and cyclohex-
imide-induced nuclear fragmentation of the cells, as
demonstrated  in  Fig.  5A.  DIDS  (1 mmol/l)  given
alone  affected  neither  the  morphology  nor  the
apoptosis induction. DIDS suppressed the TNFa and
cycloheximide-induced  endothelial  cell apoptosis in
a dose-dependent  manner, as shown  in Fig. 5A. On
the  other  hand,  the  sodium  proton  antiporter
blocker, dimethyl amiloride (0.1mmol/l), exerted no
effect  on  the  TNFa and  cycloheximide-induced
apoptosis (Fig. 5B). The chloride ion pump inhibitor,
anthracene  carboxylic  acid  (1 mmol/l),  did  not
inhibit the TNFa and cycloheximide-induced apopto-
sis of  endothelial  cells (Fig. 5C).
Discussion
TNFa and cycloheximide-induced apoptosis of
endothelial cells was due to NF-k B activation
and was different from TNFa -induced
apoptosis
TNFa has been reported to be an inducer of apoptosis
in some kinds of cells. This substance induced DNA
laddering  in  tumor  cells,  and  the  cells  displayed  a
typical morphological appearance of apoptosis.13 In
the  present  study,  we  first  demonstrated  apoptosis
due to TNFa in endothelial cells from the viewpoint
of  ion  transport.  Apoptosis  of  vascular  endothelial
cells may play an important role in the development
of increased vascular permeability and capillary leak
syndrome  during  systemic  inflammatory  response
syndrome. Irradiation can also elicit a vascular perme-
ability increase in rat lungs, resulting from apoptosis
of the pulmonary endothelial cells as judged from the
pathological findings.3 Recently, lupus anticoagulant-
induced apoptosis of endothelial cells with recogni-
tion  of  annexin  V  has  been  reported.5 It  was
suggested that apoptosis of endothelial cells may be
responsible for the vasculitis associated with systemic
lupus erythematosus. The mechanism whereby TNFa
induces apoptosis was not fully understood. Clarify-
ing  the mechanism  will  reach the goal  to treat  the
vascular  disease  such  as  vasculitis.  In  general,  it  is
known  that  TNFa elicited  apoptosis  through  its
receptor,6 subsequently  stimulating  the  death
domain, FADD, and activating caspase activity, result-
ing  in  apoptosis.6 On  the  other  hand,  TNFa also
activates  the  sphyngomyelinase  and  produces  the
ceramide, which is capable of activating the kinase.
Ion transporter in apoptosis of endothelial cells
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FIG. 4. Effect of an inhibitor of caspase on TNFa and cycloheximide-induced apoptosis of endothelial cells. (A) Endothelial cell
monolayers were treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence of various concentration of zD-
dcb, an inhibitor of ICE (0–50m mol/l), for 6h. After the incubation treatment, the cells were stained with PI, as described in
Materials and methods. * P<0.05 versus TNFa and cycloheximide-treated group; ** P<0.01 versus TNFa and cycloheximide-
treated group. Each experiment was repeated three times. (B) Endothelial cell monolayers were treated with TNFa (10ng/ml)
and cycloheximide (10m g/ml) in the presence of various concentration of zD-dcb, an inhibitor of caspase (0–50m mol/l), for 6h.
After the incubation treatment, the cells were stained with MTT, as described in Materials and methods. The data show the
mean±SEM for eight wells. ** P<0.01 versus TNFa and cycloheximide-treated group. Each experiment was repeated three
times.
(A) (B)The ceramide-activating kinase stimulates NF-k B acti-
vation.8TNFa -induced apoptosis through the FADD is
independent  on  NF-k B  activation.7 However, TNFa
can induce apoptosis through the NF-k B activation in
the  concomitant  presence  of  cycloheximide.14 We
checked  the  involvement  of  NF-k B  in  TNFa and
cycloheximide-induced  apoptosis  (Fig.  2).  In  the
endothelial cells from bovine carotid artery, TNFa and
cycloheximide  induced  apoptosis  through  PDTC-
sensitive NF-k B (Fig. 2). However, another inhibitor of
NF-k B, NAC, did not suppress the apoptosis induced
by  TNFa and  cycloheximide.  Bessho  et  al. also
reported that  etoposide-induced apoptosis of  HL-60
cells and thymocytes was inhibited by PDTC, but not
NAC.15 In  our  preliminary  data,  hydrogen  peroxide
and  cycloheximide-induced apoptosis of endothelial
cells was inhibited by either PDTC or NAC (data not
shown).  Thus,  TNFa and  cycloheximide-induced
apoptosis  is  different  from TNFa -induced  apoptosis
from the point of the involvement of NF-k B. Never-
theless, endothelial cell apoptosis induced by TNFa
and cycloheximide as well as TNFa alone, is responsi-
ble for the caspase activation (Fig. 4).
On the other hand, the reason why cycloheximide
enhances  the  TNFa -induced  apoptosis  remains
unclear.  While  TNFa directly  causes  apoptosis  of
tumor  cells,  normal  cells  are  generally  resistant.
However,  most  resistant  cells,  including  vascular
endothelial  cells,  can  be  rendered  susceptible  to
TNFa by inhibiting RNA and protein synthesis.16This
suggests that TNFa provides a cell survival signal in
addition  to  a  death  signal.  Cell  survival  factors
induced by TNFa are BCl-2 analogue, A1, FGF-1 and
nitric  oxide  (inducible  nitric  oxide  synthase).17,18
Cycloheximide may  inhibit  the protein  synthesis  of
their  antiapoptotic  factors  and  be  able  to  easily
enhance the TNFa -induced apoptosis.
TNFa and cycloheximide-induced apoptosis
was related to the tyrosine phosphatase, but
not to the sphyngomyelinase
TNFa also activates  the sphyngomyelinase  and  pro-
duces the ceramide, which is capable of activating the
kinase. The ceramide-activating kinase stimulates NF-
k B  activation.8 Nevertheless,  TNFa and  cyclohex-
H. Fujita et al.
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FIG. 5. Effects of various ion transporter inhibitors on TNFa and cycloheximide-induced apoptosis of endothelial cells. (A)
Endothelial cells were treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence of various concentrations of
DIDS (0.1–1mmol/l) for 6h. After the incubation treatment, the cells were stained with propidium iodide, as described in
Materials and methods. The percentage of apoptotic endothelial cells represents the number of apoptotic cells in the counted
100 cells (viable cells+apoptotic cells). The data show the mean±SEM for 10 wells. * P<0.05 versus TNFa and cycloheximide-
treated group. Each experiment was repeated three times. (B) Endothelial cell monolayers were treated with TNFa (10ng/ml)
and cycloheximide (10m g/ml) in the presence of dimethyl amiloride (0.1m mol/l) for 6h. After the incubation treatment, the cells
were stained with PI, as described in Materials and methods. Each experiment was repeated three times. (C) Endothelial cell
monolayers were treated with TNFa (10ng/ml) and cycloheximide (10m g/ml) in the presence of anthracene carboxylic acid
(1m mol/l) for 6h. After the incubation treatment, the cells were stained with PI, as described in Materials and methods. Each
experiment was repeated three times.
(A) (B) (C)imide-induced  apoptosis  was  not  inhibited  by  an
inhibitor of sphyngomyelinase (Fig. 3A), showing that
the apoptosis was independent  of the activation  of
sphingomyelinase through the TNFa receptor in our
assay. Slowik et al. al3o reported that TNFa -induced
apoptosis was not related to the ceramide through the
sphingomyelinase activation.19,20 In addition, Modur
et  al. reported  that  ceramide  production  in  the
endothelial cells treated with TNFa did not activate
NF-k B.21These reports may suggest the agreement on
our data.
Tyrosine kinase activation, as well as a growth factor,
is a survival factor. Tyrosine kinase inhibitors such as
herbimysin  or  genistein  caused  the  apoptosis  of
leukemic  cells,  which  was  rescued  by  the  tyrosine
phosphatase  inhibitor,  sodium  vanadate.22,23 TNFa
and cycloheximide-induced apoptosis was completely
inhibited by sodium vanadate, as shown in Fig. 3B. The
mechanism by which vanadate prevented endothelial
cells from TNFa and cycloheximide-induced apoptosis
is unclear. We speculate two possibilities: (1) vanadate
may have an action on activation of tyrosine kinase,
resulting  in  cell  survival;  (2) vanadate  may  cause  a
marked decrease in  p53, the endogenous apoptotic
inducer, as described by the previous report.24
TNFa and cycloheximide-induced apoptosis
was involved in the chloride bicarbonate
exchanger
In the present study, we attempted to use a blocker of
chloride bicarbonate exchanger to inhibit TNFa and
cycloheximide-induced  apoptosis.  In  order to main-
tain cell shape, it is necessary to regulate the osmotic
pressure  and  ion  influx.  We  first  considered  the
chloride channel, since this channel is responsible for
regulation of the anionic properties and intracellular
pH.  Moreover,  chloride  ion  influx  influences  the
shrinkage of cells.15A chloride bicarbonate exchanger
is  present  in  various  kinds  of  cells  including  ven-
tricular  myocytes,  gastric  cells,  and  renal  tubular
cells.26–28 DIDS,  one  of  the  chloride  bicarbonate
exchanger  blockers,  prevented TNFa and  cyclohex-
imide-induced apoptosis in endothelial cells. In addi-
tion, anthracene carboxylic acid, which inhibits the
chloride influx via the blockade of chloride channel,
did  not affect the TNFa and  cycloheximide-induced
apoptosis (Fig. 5C). There is one possibility that TNFa
and cycloheximide affect the function of the chloride
bicarbonate exchanger, thereby eliciting a change in
the  intracellular  chloride  ion  level  as  well  as  the
intracellular bicarbonate level. Apoptosis could then
be  induced  by  chloride  ion  efflux,  followed  by  a
change  in  the  intracellular  pH.  In  our  unpublished
data,  DIDS  inhibited  the  endothelial  cell  apoptosis
and  an  increase  in  pH,  induced  by  staurosporine,
another apoptosis inducer. Staurosporine changed the
intracellular  pH from  6.9 to 7.4 through a  chloride
bicarbonate  exchanger  (unpublished  data).  The
change  in  pH  does  occur  prior  to  the  caspase
activation  (unpublished  data).  We  speculate  that
endothelial  cell  apoptosis  induced  by  TNFa and
cycloheximide as well as staurosporine may be due to
the  activation  of  a  chloride bicarbonate  exchanger;
chloride efflux and bicarbonate influx (an increase in
pH). We consider that pH change due to a chloride
bicarbonate exchanger may be involved not in NF-k B
activation, but caspase activation, although we have
no  direct  proof.  On  other  hand,  Li  and  Eastman29
demonstrated  that  interleukin-2-stimulated  lympho-
cytes induced apoptosis of target cells via intracellular
acidosis through the sodium proton transporter. We
speculate, therefore, that  one of the common  path-
ways  of  apoptosis  may  be  via  a  sodium  proton
transporter. However, the sodium proton transporter
blocker, dimethyl amiloride, did not affect the TNFa
and  cycloheximide-induced  apoptosis  (Fig.  5B).  In
our assay  system,  a  sodium  proton  transporter was
evidently  not  related  to TNFa and  cycloheximide-
induced apoptosis.
Currently,  we  are  attempting  to  elucidate  more
precisely the mechanism responsible for the apopto-
sis, which is related to various ion pumps, including
an  examination  of  the  role  of  chloride  ion  and
intracellular pH.
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